2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
Advancing Bispecific T-cell Engager Implementation Through Peer Mentorship
Published Date:
Share
Lessons from the NCODA BTCE Mentorship Program
Authored by Michelle Taymuree, PharmD, MBA
Building a bispecific T-cell engager (BTCE) program involves decisions about staffing, workflows, training, and care coordination. Guidance from teams that have worked through these challenges can help oncology practices determine their next steps.
This NCODA case study shares lessons from the Advancing BTCE Therapy Implementation Mentorship Program, which connected ten oncology practices with experienced mentor sites. Through one-on-one discussions, webinars, roundtables, and shared resources, teams worked through questions and developed approaches suited to their practices.
What the case study explores:
- Learning from experienced peers: How mentor discussions and shared protocols helped teams work through implementation questions.
- Building the foundation: Progress in developing standard operating procedures, staff training materials, and workflows.
- Moving through stages of readiness: How practices prepare for different aspects of BTCE care, including maintenance therapy and step-up dosing.
- Working through ongoing barriers: Challenges related to staffing, finances, training, workflows, and institutional support.
- Supporting continued progress: Opportunities for ongoing collaboration, peer networking, and guidance as programs grow.
The program highlights the value of connecting oncology teams with peers who understand the work involved. It also shows how progress can take different forms, from preparing staff and establishing workflows to beginning treatment and expanding a program.
The Advancing BTCE Therapy Implementation Mentorship Program and NCODA Immunotherapy Hub were supported by an educational grant from Pfizer. NCODA maintains independent responsibility for the development and delivery of its educational programs and resources.